Clinical Trial

Pregnancy Outcomes After Breast Cancer in Young Women With Germline Pathogenic Variants in Genes Other Than BRCA

Study acronym: Beyond BCY
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The present study aims to refine the understanding of the prognostic impact of pregnancy after breast cancer in young women harboring germline pathogenic variants in breast cancer susceptibility genes other than BRCA
Trial Details
NCT Number NCT07591532
Lead Sponsor Jules Bordet Institute
Conditions Breast Cancer, Breast Cancer and Pregnancy
Enrollment 2,200 participants
Start Date 2026-06
Primary Completion 2027-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-15